Symptomatic improvement using everolimus in infants with cardiac rhabdomyoma

Symptomatic improvement using everolimus in infants with cardiac rhabdomyoma

Background: Cardiac rhabdomyoma (CR) often shows spontaneous regression and needs close follow-up. These tumors may be associated with tuberous sclerosis complex (TSC), caused by the disinhibition of m-TOR protein. Objective: The aim of the study is to observe the efficacy of everolimus in infants w...

Full description

Bibliographic Details
Main Authors: Bhargavi Dhulipudi, Shweta Bhakru, Saileela Rajan, Vinoth Doraiswamy, Nageswara Rao Koneti
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Annals of Pediatric Cardiology
Subjects:
Cardiac rhabdomyoma
everolimus
tuberous sclerosis
Online Access:http://www.annalspc.com/article.asp?issn=0974-2069;year=2019;volume=12;issue=1;spage=45;epage=48;aulast=Dhulipudi

Internet

http://www.annalspc.com/article.asp?issn=0974-2069;year=2019;volume=12;issue=1;spage=45;epage=48;aulast=Dhulipudi

Similar Items